2020
DOI: 10.1101/2020.04.09.034439
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Substrate binding modulates the conformational kinetics of the secondary multidrug transporter LmrP

Abstract: The Major Facilitator Superfamily (MFS) is the largest family of secondary active membrane transporters and is found in all domains of Life. MFS proteins are known to adopt different conformational states, yet details on the interconversion rates are crucially needed to understand or target their transport mechanism. Here, we studied the proton/multidrug antiporter LmrP as a model system for antibiotic resistance development in bacteria. The conformational cycle of LmrP is triggered by the protonation of a net… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(9 citation statements)
references
References 51 publications
0
9
0
Order By: Relevance
“…[90][91][92][93][94][95][96] The impact of mutations on function can be monitored by ATPase assays [79,90,[97][98][99][100][101] or transport assays. [78,90,[105][106][107][108]93,94,96,97,100,[102][103][104] In transport assays, the protein is either overexpressed in a cell or incorporated into liposomes and the accumulation of fluorescent [78,97,105] or radiolabeled substrate [90,93,94,96,100,102,103,[106][107][108] in the compartment (cell or vesicle) is measured. Good examples for such careful controls are LmrP transporter variants whose activities were checked with the fluorescent ligand Hoechst, [105] or variants of the Glt Ph transporter in liposomes where the uptake of the radioactive substrate [ 3 H]-Asp was used to confirm activity.…”
Section: Specific Labeling and Functionalitymentioning
confidence: 99%
See 4 more Smart Citations
“…[90][91][92][93][94][95][96] The impact of mutations on function can be monitored by ATPase assays [79,90,[97][98][99][100][101] or transport assays. [78,90,[105][106][107][108]93,94,96,97,100,[102][103][104] In transport assays, the protein is either overexpressed in a cell or incorporated into liposomes and the accumulation of fluorescent [78,97,105] or radiolabeled substrate [90,93,94,96,100,102,103,[106][107][108] in the compartment (cell or vesicle) is measured. Good examples for such careful controls are LmrP transporter variants whose activities were checked with the fluorescent ligand Hoechst, [105] or variants of the Glt Ph transporter in liposomes where the uptake of the radioactive substrate [ 3 H]-Asp was used to confirm activity.…”
Section: Specific Labeling and Functionalitymentioning
confidence: 99%
“…[78,90,[105][106][107][108]93,94,96,97,100,[102][103][104] In transport assays, the protein is either overexpressed in a cell or incorporated into liposomes and the accumulation of fluorescent [78,97,105] or radiolabeled substrate [90,93,94,96,100,102,103,[106][107][108] in the compartment (cell or vesicle) is measured. Good examples for such careful controls are LmrP transporter variants whose activities were checked with the fluorescent ligand Hoechst, [105] or variants of the Glt Ph transporter in liposomes where the uptake of the radioactive substrate [ 3 H]-Asp was used to confirm activity. [108] An elegant tool to fully avoid direct protein modifications are smFRET sensors that selectively probe the presence of substrates in vesicles (Figure 3).…”
Section: Specific Labeling and Functionalitymentioning
confidence: 99%
See 3 more Smart Citations